- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02170558
Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With TM-Ardis
January 22, 2019 updated by: Zimmer Biomet
Evaluating Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With Trabecular Metal Implants (TM-Ardis)
To determine if the subject metal reduction software helps to better visualize bone interphase and fusion reliability.
Assess whether the appropriate procedural modification facilitates clearer images when implanted with a trabecular metal spinal implant
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
To determine if the subject metal reduction software helps to better visualize bone interphase and fusion reliability, and assess whether the appropriate procedural modification facilitates clearer images when implanted with a trabecular metal spinal implant.
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Idaho
-
Boise, Idaho, United States, 83706
- St Alphonsus Regional Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients who are having a spinal fusion procedure with TM-Ardis and meet the requirements below are eligible for this study.
Description
Inclusion Criteria:
- A signed informed consent.
- Male or non-pregnant female scheduled for Trabecular Metal (TM - Ardis) implant, single level lumbar.
- Participant must be at least 18 years of age.
Exclusion Criteria:
- Patient is pregnant Patient is unable to comprehend the requirements of the study.
- Patient is unable to undergo scanning (due to body habitus, inability to comply with positioning requirements, etc.).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients implanted w/TM-Ardis
Patients who are receiving a TM-Ardis implant for degenerative disc disease will have a CT scan immediate post op (2 weeks) and again at 6 months to determine if fusion can be assessed with the study metal reduction software.
Will utilize TM- Ardis implant and Metal Reduction CT software
|
TM- Ardis implant and Metal Reduction CT software
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CT scan to determine if the study software can reduce metal scatter on the scan.
Time Frame: 6 month post operative
|
Each CT scan will be evaluated to asses if you can visualize fusion, bone interface, and/or device migration with an experimental metal reduction software for CT scan
|
6 month post operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joel Batts, Zimmer Biomet Spine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
June 18, 2014
First Submitted That Met QC Criteria
June 20, 2014
First Posted (Estimate)
June 23, 2014
Study Record Updates
Last Update Posted (Actual)
January 24, 2019
Last Update Submitted That Met QC Criteria
January 22, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSU2013-05S
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Centinel SpineAvaniaEnrolling by invitationDegenerative Disc Disease | Symptomatic Cervical Disc Disease | Cervical Spine Degenerative Disc Disease | Cervical Spine Degenerative DiseaseGermany
-
Synergy Spine SolutionsMCRAActive, not recruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRAActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of